1-anilino-8-naphthalenesulfonate has been researched along with Liver Dysfunction in 75 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
Excerpt | Relevance | Reference |
---|---|---|
"Despite this, the genetic susceptibility to chronic liver disease in this country has not been investigated." | 1.56 | Genetic Susceptibility to Chronic Liver Disease in Individuals from Pakistan. ( Ahmad, IN; Ciociola, E; Dar, FS; Kaukab Raja, G; Mancina, RM; Moaeen-Ud-Din, M; Naqvi, SMS; Raja, AM; Romeo, S, 2020) |
"Childhood obesity is a growing problem worldwide." | 1.36 | The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life. ( Baroni, MG; Cambuli, VM; Congiu, T; Cossu, E; Huang-Doran, I; Incani, M; Loche, S; Matta, V; Pilia, S; Romeo, S; Sentinelli, F, 2010) |
"All patients with NAFLD underwent liver biopsy." | 1.36 | Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease. ( Chayama, K; Hotta, K; Hyogo, H; Mizusawa, S; Nakajima, A; Nakao, K; Ochi, H; Sekine, A; Ueno, T; Yoneda, M, 2010) |
"The mortality associated with acute pancreatitis (AP) is largely attributable to abnormalities that occur in distant organs and supportive care remains the only treatment for patients with these complications." | 1.34 | Therapeutic treatment with poly(ADP-ribose) polymerase inhibitors attenuates the severity of acute pancreatitis and associated liver and lung injury. ( Berenguer-Pina, JJ; Hernández-Espinosa, D; Mota, R; Parrilla, P; Sánchez-Bueno, F; Yélamos, J, 2007) |
"A clinical diagnosis of acute pancreatitis is often difficult to obtain." | 1.33 | Comparison of lipase activity in peritoneal fluid of dogs with different pathologies--a complementary diagnostic tool in acute pancreatitis? ( Guija de Arespacochaga, A; Hittmair, KM; Schwendenwein, I, 2006) |
"In 35 patients with established acute pancreatitis 143 sera were investigated in the course of disease." | 1.27 | [Diagnostic value of lipase and isoamylase determination. Monitoring studies in patients with proven and suspected pancreatitis]. ( Bode, C; Dürr, GH, 1983) |
"Evidence of acute pancreatitis was sought in 35 patients with fulminant hepatic failure." | 1.27 | Frequency of pancreatitis in fulminant hepatic failure using isoenzyme markers. ( Ede, RJ; Marshall, WJ; Moore, KP; Williams, R, 1988) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 43 (57.33) | 18.7374 |
1990's | 7 (9.33) | 18.2507 |
2000's | 7 (9.33) | 29.6817 |
2010's | 15 (20.00) | 24.3611 |
2020's | 3 (4.00) | 2.80 |
Authors | Studies |
---|---|
Liao, S | 1 |
An, K | 1 |
Liu, Z | 1 |
He, H | 1 |
An, Z | 1 |
Su, Q | 1 |
Li, S | 1 |
Tardelli, M | 1 |
Bruschi, FV | 1 |
Trauner, M | 1 |
Raja, AM | 1 |
Ciociola, E | 1 |
Ahmad, IN | 1 |
Dar, FS | 1 |
Naqvi, SMS | 1 |
Moaeen-Ud-Din, M | 1 |
Kaukab Raja, G | 1 |
Romeo, S | 3 |
Mancina, RM | 1 |
Haemmerle, G | 1 |
Lass, A | 1 |
Yang, J | 1 |
Trépo, E | 2 |
Nahon, P | 2 |
Cao, Q | 1 |
Moreno, C | 1 |
Letouzé, E | 1 |
Imbeaud, S | 1 |
Gustot, T | 1 |
Deviere, J | 1 |
Debette, S | 1 |
Amouyel, P | 1 |
Bioulac-Sage, P | 1 |
Calderaro, J | 1 |
Ganne-Carrié, N | 1 |
Laurent, A | 1 |
Blanc, JF | 1 |
Guyot, E | 1 |
Sutton, A | 1 |
Ziol, M | 1 |
Zucman-Rossi, J | 2 |
Nault, JC | 1 |
Hellerbrand, C | 1 |
Larrieta-Carrasco, E | 1 |
León-Mimila, P | 1 |
Villarreal-Molina, T | 1 |
Villamil-Ramírez, H | 1 |
Romero-Hidalgo, S | 1 |
Jacobo-Albavera, L | 1 |
Gutiérrez-Vidal, R | 1 |
López-Contreras, BE | 1 |
Guillén-Pineda, LE | 1 |
Sánchez-Muñoz, F | 1 |
Bojalil, R | 1 |
Mejía-Domínguez, AM | 1 |
Méndez-Sánchez, N | 1 |
Domínguez-López, A | 1 |
Aguilar-Salinas, CA | 1 |
Canizales-Quinteros, S | 1 |
Karlsen, TH | 1 |
Lammert, F | 3 |
Thompson, RJ | 1 |
Martinez-Lopez, N | 1 |
Singh, R | 1 |
Huang, H | 1 |
An, B | 1 |
Xin, Y | 1 |
Jiang, M | 1 |
Jin, W | 1 |
Lin, Z | 1 |
Jiang, X | 1 |
Xuan, S | 1 |
Nader, MA | 1 |
Wagih, HM | 1 |
Lee, JF | 1 |
Wang, D | 1 |
Hsu, YH | 1 |
Chen, HI | 1 |
LAGERLOF, HO | 1 |
Park, JH | 1 |
Lee, TH | 1 |
Cheon, SL | 1 |
Sun, JH | 1 |
Choi, IK | 1 |
Kim, YS | 1 |
Choi, YW | 1 |
Kang, YW | 1 |
Worning, H | 1 |
Müllertz, S | 1 |
Thaysen, EH | 1 |
Bang, HO | 1 |
Sentinelli, F | 1 |
Cambuli, VM | 1 |
Incani, M | 1 |
Congiu, T | 1 |
Matta, V | 1 |
Pilia, S | 1 |
Huang-Doran, I | 1 |
Cossu, E | 1 |
Loche, S | 1 |
Baroni, MG | 1 |
Krawczyk, M | 1 |
Grünhage, F | 1 |
Zimmer, V | 2 |
Hotta, K | 1 |
Yoneda, M | 1 |
Hyogo, H | 1 |
Ochi, H | 1 |
Mizusawa, S | 1 |
Ueno, T | 1 |
Chayama, K | 1 |
Nakajima, A | 1 |
Nakao, K | 1 |
Sekine, A | 1 |
Serfaty, L | 1 |
Castera, L | 1 |
Marcellin, P | 1 |
Li, Q | 1 |
Qu, HQ | 1 |
Rentfro, AR | 1 |
Grove, ML | 1 |
Mirza, S | 1 |
Lu, Y | 1 |
Hanis, CL | 1 |
Fallon, MB | 1 |
Boerwinkle, E | 1 |
Fisher-Hoch, SP | 1 |
McCormick, JB | 1 |
CONNOR, WE | 1 |
ECKSTEIN, JW | 1 |
STORK, A | 1 |
KUCEROVA, L | 1 |
MORGANO, G | 1 |
SOLYMOSS, B | 1 |
ZIMMERMAN, HJ | 1 |
WEST, M | 1 |
TICKTIN, HE | 2 |
TRUJILLO, NP | 1 |
EVANS, PF | 1 |
ROE, JH | 2 |
Di Pascoli, L | 1 |
Lion, A | 1 |
Milazzo, D | 1 |
Caregaro, L | 1 |
Kinoshita, M | 1 |
Guija de Arespacochaga, A | 1 |
Hittmair, KM | 1 |
Schwendenwein, I | 1 |
Mota, R | 1 |
Sánchez-Bueno, F | 1 |
Berenguer-Pina, JJ | 1 |
Hernández-Espinosa, D | 1 |
Parrilla, P | 1 |
Yélamos, J | 1 |
Verola, O | 1 |
de Roquancourt, A | 1 |
Chanu, B | 1 |
Rouffy, J | 1 |
Brocheriou, C | 1 |
Dürr, GH | 1 |
Bode, C | 1 |
Bornschein, W | 1 |
Fukushima, N | 1 |
Yamamoto, K | 1 |
Ozaki, I | 1 |
Kajihara, S | 1 |
Motomura, M | 1 |
Mizuta, T | 1 |
Setoguchi, Y | 1 |
Yanagita, T | 1 |
Sakai, T | 1 |
Patil, S | 1 |
Kanase, A | 1 |
Varute, AT | 1 |
Bruner, JM | 1 |
Steiner, JM | 1 |
Williams, DA | 1 |
Van Alstine, WG | 1 |
Blevins, W | 1 |
McDonald, MC | 1 |
Filipe, HM | 1 |
Thiemermann, C | 1 |
Wang, W | 1 |
Li, W | 1 |
Ikeda, Y | 1 |
Miyagawa, JI | 1 |
Taniguchi, M | 1 |
Miyoshi, E | 1 |
Sheng, Y | 1 |
Ekuni, A | 1 |
Ko, JH | 1 |
Yamamoto, Y | 1 |
Sugimoto, T | 1 |
Yamashita, S | 1 |
Matsuzawa, Y | 1 |
Grabowski, GA | 1 |
Honke, K | 1 |
Taniguchi, N | 1 |
Burlina, A | 1 |
Zaninotto, M | 1 |
Bianchi, M | 1 |
Galzigna, L | 2 |
Goldberg, DM | 1 |
Sauar, J | 3 |
Holme, R | 1 |
Blomhoff, JP | 2 |
Klose, G | 3 |
Windelband, J | 2 |
Weizel, A | 1 |
Greten, H | 3 |
Stokke, KT | 1 |
Skrede, S | 1 |
Hansen, W | 2 |
Schmidt, H | 1 |
Witthöft, C | 1 |
Augustin, J | 1 |
Kommerell, B | 1 |
Krystev, L | 1 |
Tashev, T | 1 |
Brailski, KH | 1 |
Stoianov, S | 1 |
Kolarski, V | 1 |
Richter, T | 1 |
Müller, D | 1 |
Senger, H | 1 |
Beyreiss, K | 1 |
Hegele, RA | 1 |
Miller, JP | 1 |
Tietz, NW | 1 |
Huang, WY | 1 |
Rauh, DF | 1 |
Shuey, DF | 1 |
Ede, RJ | 1 |
Moore, KP | 1 |
Marshall, WJ | 1 |
Williams, R | 1 |
Nusser, E | 1 |
Donath, H | 1 |
Iwai, N | 1 |
Müller, P | 1 |
Felin, R | 1 |
Lambrecht, J | 1 |
Agostini, B | 1 |
Wieland, H | 1 |
Rost, W | 1 |
Seidel, D | 1 |
Brulina, A | 1 |
Boccato, P | 1 |
Silen, W | 1 |
Whitaker, JF | 1 |
Bondar', ZA | 1 |
Podymova, SD | 1 |
Zolotnitskaia, RP | 1 |
Saluznía, AI | 1 |
Plotnikova, NM | 1 |
Holt, PR | 1 |
Waterlow, JC | 1 |
Chaun, H | 1 |
King, DM | 1 |
Gofton, JP | 1 |
Sutherland, WH | 1 |
Bogoch, A | 1 |
Burke, JA | 1 |
Schubert, WK | 1 |
Herfort, K | 1 |
Fric, P | 1 |
Bartos, V | 1 |
Schneider, M | 1 |
Kuno, N | 1 |
Dolíhal, J | 1 |
Továrek, J | 1 |
Vojtková, J | 1 |
Walther, M | 1 |
Unger, E | 1 |
Jaross, W | 1 |
Hanefeld, M | 1 |
Visset, J | 1 |
Le Bodic, MF | 1 |
Le Bodic, L | 1 |
Drianno, JC | 1 |
Baudry, G | 1 |
Klümper, A | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Is Adrenal Insufficiency Under-diagnosed in Hospitalized Cirrhosis Patients?[NCT03368066] | Phase 3 | 100 participants (Actual) | Interventional | 2018-01-29 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Patients who died within 30 days of enrollment (NCT03368066)
Timeframe: 30 days
Intervention | Participants (Count of Participants) |
---|---|
Normal Adrenal Response | 4 |
Relative Adrenal Insufficiency | 4 |
Patients who died within 6 months of enrollment (NCT03368066)
Timeframe: 6 months
Intervention | Participants (Count of Participants) |
---|---|
Normal Adrenal Response | 9 |
Relative Adrenal Insufficiency | 15 |
Patients who died within 90 days of enrollment (NCT03368066)
Timeframe: 90 days
Intervention | Participants (Count of Participants) |
---|---|
Normal Adrenal Response | 5 |
Relative Adrenal Insufficiency | 12 |
Patients who died within the same hospitalization as enrollment (NCT03368066)
Timeframe: Within Hospitalization
Intervention | Participants (Count of Participants) |
---|---|
Normal Adrenal Response | 1 |
Relative Adrenal Insufficiency | 1 |
Patients who received a liver transplant within 6 months of enrollment (NCT03368066)
Timeframe: 6 months
Intervention | Participants (Count of Participants) |
---|---|
Normal Adrenal Response | 8 |
Relative Adrenal Insufficiency | 6 |
Patients who received a liver transplant within 90 days of enrollment (NCT03368066)
Timeframe: 90 days
Intervention | Participants (Count of Participants) |
---|---|
Normal Adrenal Response | 6 |
Relative Adrenal Insufficiency | 5 |
A percent quantification of serum cholesterol esterification will be measured via blood draw. Low values represent deficiency in esterification, which is a surrogate measure of lecthicin-cholesterol acetyltransferase (LCAT) enzymatic deficiency. (NCT03368066)
Timeframe: 24 hours
Intervention | Participants (Count of Participants) |
---|---|
Normal Adrenal Response | 10 |
Relative Adrenal Insufficiency | 11 |
Patients will have their free cortisol levels measured to assess for deficiency. (NCT03368066)
Timeframe: 24 hours
Intervention | Participants (Count of Participants) |
---|---|
Normal Adrenal Response | 6 |
Relative Adrenal Insufficiency | 1 |
A baseline total cortisol level will be obtained and then patients will receive a standard-dose synthetic ACTH (250mcg of Cosyntropin) stimulation test to assess for the presence of adrenal insufficiency. RAI is defined as a change in the total cortisol level in response to the stimulation test of <9mcg/dL when measured 60 minutes after the Cosyntropin is administered. (NCT03368066)
Timeframe: 24 hours
Intervention | Participants (Count of Participants) |
---|---|
Hospitalized Cirrhosis Patients | 37 |
A peripheral blood smear will be obtained and assessed for presence of acanthocytes (spur cells). Spur cell anemia is defined as a serum hemoglobin < 10g/dL and the presence of >= 5% spur cells on blood smear. (NCT03368066)
Timeframe: 24 hours
Intervention | Participants (Count of Participants) |
---|---|
Normal Adrenal Response | 6 |
Relative Adrenal Insufficiency | 8 |
Transplant and Death are considered equivalent outcomes (NCT03368066)
Timeframe: 6 months
Intervention | Participants (Count of Participants) |
---|---|
Normal Adrenal Response | 41 |
Relative Adrenal Insufficiency | 16 |
12 reviews available for 1-anilino-8-naphthalenesulfonate and Liver Dysfunction
Article | Year |
---|---|
The Role of Metabolic Lipases in the Pathogenesis and Management of Liver Disease.
Topics: Humans; Lipase; Lipid Metabolism; Liver Diseases; Signal Transduction | 2020 |
Genetically modified mouse models to study hepatic neutral lipid mobilization.
Topics: Animals; Disease Models, Animal; Humans; Lipase; Lipid Metabolism; Liver; Liver Diseases; Mice | 2019 |
Genetics of liver disease: From pathophysiology to clinical practice.
Topics: Exome; Genetic Predisposition to Disease; Genetics; Genome-Wide Association Study; Humans; Lipase; L | 2015 |
Autophagy and Lipid Droplets in the Liver.
Topics: Animals; Autophagy; Autophagy-Related Protein 7; Gene Deletion; Hepatocytes; Homeostasis; Humans; Li | 2015 |
PNPLA3 gene in liver diseases.
Topics: Genome-Wide Association Study; Humans; Lipase; Liver Diseases; Membrane Proteins | 2016 |
Genetics in liver disease: new concepts.
Topics: Autoimmune Diseases; Cholestasis; Fatty Liver; Genetic Predisposition to Disease; Genome-Wide Associ | 2011 |
[ON THE PROBLEM AND POSSIBILITIES OF ENZYME DIAGNOSIS].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Bone Diseases; Bone Marrow; Central Nervous Syste | 1964 |
[Hepatic triglyceride lipase (HTGL)].
Topics: Arteriosclerosis; Biomarkers; Carrier Proteins; Cholesterol Ester Transfer Proteins; Cholesterol, HD | 2004 |
Clinical enzymology.
Topics: Acid Phosphatase; Alkaline Phosphatase; alpha-Amylases; Biliary Tract Diseases; Clinical Enzyme Test | 1976 |
Dyslipoproteinaemia of liver disease.
Topics: Cholestasis; Humans; Hypolipoproteinemias; Lipase; Lipoprotein-X; Lipoproteins, HDL; Lipoproteins, L | 1990 |
Medium chain triglycerides.
Topics: Bile Acids and Salts; Biological Transport; Diet Therapy; Dietary Fats; Fatty Acids; Gastrointestina | 1971 |
Enzyme changes in malnutrition.
Topics: Alkaline Phosphatase; Amylases; Carboxy-Lyases; Child; Cholinesterases; Creatine Kinase; Humans; Inf | 1970 |
1 trial available for 1-anilino-8-naphthalenesulfonate and Liver Dysfunction
Article | Year |
---|---|
PNPLA3 polymorphisms and liver aminotransferase levels in a Mexican American population.
Topics: Adult; Age Factors; Alanine Transaminase; Aspartate Aminotransferases; Female; Genotype; Humans; Lip | 2012 |
62 other studies available for 1-anilino-8-naphthalenesulfonate and Liver Dysfunction
Article | Year |
---|---|
Genetic variants associated with metabolic dysfunction-associated fatty liver disease in western China.
Topics: Genetic Predisposition to Disease; Genotype; Glucose; Humans; Lipase; Liver; Liver Diseases; Membran | 2022 |
Genetic Susceptibility to Chronic Liver Disease in Individuals from Pakistan.
Topics: 17-Hydroxysteroid Dehydrogenases; Acyltransferases; Adaptor Proteins, Signal Transducing; Adult; Chr | 2020 |
PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases.
Topics: Carcinoma, Hepatocellular; Cohort Studies; Female; Genetic Predisposition to Disease; Genetic Variat | 2019 |
Inhibition of monoacylglycerol lipase for the treatment of liver disease: tempting but still playing with fire.
Topics: Anti-Inflammatory Agents; Humans; Lipase; Liver Diseases; Monoacylglycerol Lipases | 2019 |
Association of the I148M/PNPLA3 variant with elevated alanine transaminase levels in normal-weight and overweight/obese Mexican children.
Topics: Age of Onset; Alanine Transaminase; Amino Acid Substitution; Case-Control Studies; Child; Female; Ge | 2013 |
[Role of SREBP-1c in risk of liver disease associated with the triacylglycerol lipase PNPLA3 I148M variant].
Topics: Cell Line, Tumor; Humans; Lipase; Liver Diseases; Membrane Proteins; Risk Factors; Sterol Regulatory | 2015 |
Nilotinib, a tyrosine kinase inhibitor exhibits protection against acute pancreatitis-induced lung and liver damage in rats.
Topics: Acute Disease; Amylases; Animals; Anti-Inflammatory Agents; Antioxidants; Arginine; Biomarkers; Cyto | 2017 |
Oxidative and nitrosative mediators in hepatic injury caused by whole body hyperthermia in rats.
Topics: Alanine Transaminase; Amylases; Animals; Aspartate Aminotransferases; Blood Urea Nitrogen; Creatine | 2008 |
Normal serum esterase and pancreatic lipase in serum in liver diseases.
Topics: Blood; Blood Chemical Analysis; Esterases; Humans; Hydrolases; Lipase; Liver Diseases; Metabolism; P | 1947 |
[Severe acute liver and pancreas damage in anorexia nervosa].
Topics: Acute Disease; Adult; Alanine Transaminase; Anorexia Nervosa; Aspartate Aminotransferases; Body Mass | 2009 |
pH and concentration of pancreatic enzymes in aspirates from the human duodenum during digestion of a standard meal in patients with biliary or hepatic disorders.
Topics: alpha-Amylases; Biliary Tract Diseases; Chymotrypsin; Digestion; Duodenum; Female; Humans; Hydrogen- | 1967 |
The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life.
Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Child; Cohort Studies; Fatty Liver; F | 2010 |
Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: non-invasive elastography-based study in chronic liver disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Base Sequence; Chronic Disease; Cross-Sectional Studies; | 2011 |
Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.
Topics: Adult; Age Factors; Aged; Alanine Transaminase; Alleles; Aspartate Aminotransferases; Body Mass Inde | 2010 |
First European Young Hepatologist Workshop: topics and advances.
Topics: Carcinoma, Hepatocellular; End Stage Liver Disease; European Union; Fatty Liver; Genetic Markers; Hu | 2011 |
The removal of lipoprotein lipase from the blood by the normal and diseased liver.
Topics: Humans; Lipase; Lipoprotein Lipase; Lipoproteins; Liver; Liver Diseases | 1959 |
[Postheparin esterase and clearing factor in liver diseases].
Topics: Esterases; Heparin; Humans; Lipase; Lipoprotein Lipase; Liver Diseases | 1962 |
[RECENT VIEWS ON LIPASES IN INTERNAL MEDICINE].
Topics: Clinical Enzyme Tests; Diabetes Mellitus; Gastroenterology; Humans; Kidney Diseases; Lipase; Lipid M | 1963 |
SERUM ENZYMES IN GASTROINTESTINAL DISEASES.
Topics: Alanine Transaminase; Alcohol Oxidoreductases; Alkaline Phosphatase; Aminopeptidases; Amylases; Aspa | 1964 |
DIAGNOSTIC VALUE OF A NEW SERUM LIPASE METHOD.
Topics: Amylases; Blood; Clinical Enzyme Tests; Diagnosis; Humans; Kidney Diseases; Lipase; Liver Diseases; | 1965 |
Acute liver damage in anorexia nervosa.
Topics: Acute Disease; Adult; Alanine Transaminase; Amylases; Anorexia Nervosa; Body Mass Index; Creatine Ki | 2004 |
Comparison of lipase activity in peritoneal fluid of dogs with different pathologies--a complementary diagnostic tool in acute pancreatitis?
Topics: Abdominal Injuries; Abdominal Neoplasms; Acute Disease; Animals; Ascites; Ascitic Fluid; Biomarkers; | 2006 |
Therapeutic treatment with poly(ADP-ribose) polymerase inhibitors attenuates the severity of acute pancreatitis and associated liver and lung injury.
Topics: Acute Disease; Alanine Transaminase; Amylases; Animals; Aspartate Aminotransferases; Choline; Dietar | 2007 |
[Hepatic cholesterolosis. Histological, histochemical and ultrastructural study of 2 cases].
Topics: Cholesterol Esters; Female; Histocytochemistry; Humans; Lipase; Lipid Metabolism, Inborn Errors; Liv | 1983 |
[Diagnostic value of lipase and isoamylase determination. Monitoring studies in patients with proven and suspected pancreatitis].
Topics: Acute Disease; Adolescent; Adult; Aged; Child; Child, Preschool; Chronic Disease; Clinical Enzyme Te | 1983 |
[Clinical studies using a photometric method for determining serum lipase activity].
Topics: Humans; Lipase; Liver Diseases; Pancreatic Diseases; Photometry | 1984 |
Hepatic triglyceride lipase mRNA expression in various liver diseases.
Topics: Gene Expression; Humans; Lipase; Liver; Liver Diseases; RNA, Messenger | 1993 |
Effect of hepatoprotective ayurvedic drugs on lipolytic activities during CCl4 induced acute hepatic injury in albino rats.
Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; India; Lipase; Liver; Liver D | 1993 |
High feline trypsin-like immunoreactivity in a cat with pancreatitis and hepatic lipidosis.
Topics: Alanine Transaminase; Alkaline Phosphatase; Amylases; Animals; Antibodies; Bilirubin; Cat Diseases; | 1997 |
Effects of inhibitors of the activity of poly (ADP-ribose) synthetase on the organ injury and dysfunction caused by haemorrhagic shock.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Benzamides; Blood Pressure; Creatine Kin | 1999 |
Ectopic expression of alpha1,6 fucosyltransferase in mice causes steatosis in the liver and kidney accompanied by a modification of lysosomal acid lipase.
Topics: Animals; Fucosyltransferases; Humans; Kidney; Lipase; Lipids; Liver; Liver Diseases; Lysosomes; Mice | 2001 |
Clinical importance of lipase determination by the turbidimetric procedure as compared with determination by a chromatrographic procedure.
Topics: Adult; Amylases; Chromatography; Clinical Enzyme Tests; Evaluation Studies as Topic; Female; Humans; | 1977 |
Triglyceride lipase activity in postheparin plasma and plasma lipoproteins in liver disease.
Topics: Adult; Aged; Female; Heparin; Humans; Lipase; Lipoprotein Lipase; Lipoproteins; Lipoproteins, HDL; L | 1978 |
Secondary hypertriglyceridaemia in patients with parenchymal liver disease.
Topics: Adolescent; Adult; Aged; Female; Humans; Lipase; Lipoprotein Lipase; Liver Diseases; Male; Middle Ag | 1977 |
Plasma estrogens and hepatic lipase in postheparin plasma with special reference to liver disease.
Topics: Adult; Estradiol; Estrogens; Female; Follicle Stimulating Hormone; Heparin; Humans; Lipase; Lipoprot | 1979 |
Hepatic lipase and lipoprotein lipase in postheparin plasma in liver disease. relations to plasma proteins.
Topics: Blood Proteins; Fatty Acids, Nonesterified; Heparin; Lipase; Lipoprotein Lipase; Liver; Liver Diseas | 1978 |
[Proceedings: Fat tolerance and postheparin lipases in patients with liver diseases].
Topics: Dietary Fats; Fatty Liver; Heparin; Hepatitis; Humans; Lipase; Liver Cirrhosis; Liver Diseases; Mono | 1975 |
[Diagnostic relevance of provocative (evocative) blood enzyme tests in pancreatic disease (author's transl)].
Topics: Amylases; Cholecystokinin; Chronic Disease; Diabetes Mellitus; Enzymes; Gastrointestinal Diseases; H | 1976 |
[Studies on hypertriglyceridemia in liver diseases by means of measurements of hepatic triglyceride lipase and plasma lipoprotein lipase activity in the heparinized plasma].
Topics: Female; Humans; Lipase; Lipoprotein Lipase; Liver; Liver Diseases; Male; Triglycerides | 1976 |
[Fat tolerance and post-heparin lipases in patients with liver diseases].
Topics: Heparin; Humans; Lipase; Lipid Metabolism; Liver; Liver Diseases | 1975 |
[Histoenzymatic studies in certain liver diseases].
Topics: Acid Phosphatase; Alkaline Phosphatase; Esterases; Humans; Kupffer Cells; Lipase; Liver Diseases | 1975 |
[Determination of exocrine pancreatic function in childhood with the pancreozymin-secretin test].
Topics: Amylases; Child; Child, Preschool; Cholecystokinin; Cystic Fibrosis; Diagnosis, Differential; Exocri | 1992 |
The molecular basis of hepatic lipase deficiency.
Topics: DNA; Family; Humans; Lipase; Liver; Liver Diseases | 1991 |
Laboratory tests in the differential diagnosis of hyperamylasemia.
Topics: Amylases; Biliary Tract Diseases; Colorimetry; Diagnosis, Differential; Humans; Intestinal Obstructi | 1986 |
Frequency of pancreatitis in fulminant hepatic failure using isoenzyme markers.
Topics: Acute Disease; Adolescent; Adult; Amylases; Clinical Enzyme Tests; Female; Humans; Isoenzymes; Lipas | 1988 |
[Clinical therapeutical experiences with mexase].
Topics: Adult; Aged; Amylases; Biliary Tract Diseases; Bromelains; Chymotrypsin; Clioquinol; Dehydrocholic A | 1968 |
Histochemical studies of small and large bowels. 2. Histological and histochemical changes of human small intestine in various pathological states (results of intestinal biopsies in 102 cases).
Topics: Acid Phosphatase; Adolescent; Adult; Biopsy; Blind Loop Syndrome; Female; Gastrectomy; Gastric Juice | 1969 |
Hypertriglyceridaemia secondary to liver disease.
Topics: Adult; Aged; Bilirubin; Cholestasis; Electrophoresis, Polyacrylamide Gel; Hepatitis; Humans; Hyperli | 1974 |
[Isolation and classification of a hepatic plasma lipase--first clinical results in patients with various liver diseases].
Topics: Humans; Lipase; Liver Diseases | 1974 |
Lipase activity in ethionine pancreatic lesions.
Topics: Animals; Chemical and Drug Induced Liver Injury; Esterases; Ethionine; Lipase; Liver; Liver Diseases | 1972 |
Pancreatectomy and liver damage.
Topics: Animals; Dogs; Gastric Juice; Hydrogen-Ion Concentration; Lipase; Liver Diseases; Pancreas; Pancreat | 1973 |
A rapid and specific method for the determination of pancreatic lipase in serum and urine.
Topics: Animals; Buffers; Colorimetry; Diazonium Compounds; Enzyme Activation; Humans; Hydrolysis; Lipase; L | 1973 |
[Clinical significance of laboratory indicators in patients with chronic liver diseases].
Topics: Alanine Transaminase; Alkaline Phosphatase; Amylases; Aspartate Aminotransferases; Bilirubin; Choles | 1974 |
Sarcoidosis of the pancreas.
Topics: Animals; Diet Therapy; Fatty Liver; Fibroblasts; Granuloma; Humans; Lipase; Liver; Liver Diseases; L | 1972 |
Deficient activity of acid lipase in cholesterol-ester storage disease.
Topics: Cholesterol; Esters; Hepatomegaly; Humans; Lipase; Lipid Metabolism, Inborn Errors; Lipidoses; Liver | 1971 |
[Direct determination of secretion capacity of the pancreas after hormonal stimulation. Diagnostic significance of the secretin and pancreozymin tests].
Topics: Amylases; Bile; Biliary Tract Diseases; Cholecystokinin; Chronic Disease; Duodenal Diseases; Duodenu | 1971 |
Determination and clinical significance of serum lipase.
Topics: Chemistry, Clinical; Clinical Enzyme Tests; Enzymes; Heparin; Humans; In Vitro Techniques; Kidney Di | 1966 |
A new method for serum lipase determination and serum lipase activity in liver diseases determined by this method.
Topics: Adult; Animals; Bile Acids and Salts; Dogs; Humans; Lipase; Liver Diseases; Liver Function Tests; Ma | 1969 |
[Our experiences with a new method for the determination of serum lipase].
Topics: Cholecystitis; Female; Humans; Kidney Diseases; Lipase; Liver Diseases; Male; Methods | 1969 |
[Studies on the effect of essential phospholipids in essential hypertriglyceridemia].
Topics: Cholesterol; Diabetes Mellitus; Humans; Lipase; Lipids; Liver Diseases; Palpation; Phospholipids; Pu | 1969 |
[Study of enzymatic toxemia in acute experimental pancreatitis in dogs. Methods of controlling its diffusion].
Topics: Acute Disease; Adipose Tissue; Amylases; Animals; Brain Edema; Dogs; Hypertension; Hypothermia, Indu | 1970 |
[Drug therapy of meteorism. Experiences with Pankreoflat].
Topics: Amylases; Cholecystitis; Cholelithiasis; Flatulence; Heart Diseases; Humans; Lipase; Liver Diseases; | 1967 |